Cargando…

2596. Invasive Fungal Disease in Patients with GATA2 Variant Hematologic Malignancy

BACKGROUND: Patients with hematologic malignancies (HM) are at risk of invasive fungal disease (IFD). Identification of those patients at the highest risk for IFD would help optimize prophylactic or preemptive treatment decisions in this population. We previously found that among patients with myelo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bold, Tyler D, Vedula, Rahul S, Cheng, Matthew P, Marty, Francisco M, Lindsley, R Coleman
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810134/ http://dx.doi.org/10.1093/ofid/ofz360.2274

Ejemplares similares

1140. GATA2 Mutations Are Frequently Identified Among Patients With Myeloid Malignancies Who Develop Invasive Aspergillosis
por: Bold, Tyler D, et al.
Publicado: (2018)

408. Invasive Fungal Petrositis and Carotiditis (IFPAC) Syndrome in Immunocompromised Hosts: An Unrecognized, Often Catastrophic Invasive Fungal Disease (IFD)
por: Little, Jessica, et al.
Publicado: (2018)

An internet survey of 2,596 people with fibromyalgia
por: Bennett, Robert M, et al.
Publicado: (2007)

415. Breakthrough Invasive Fungal Infections in Adult Hematologic Malignancy Patients Receiving Isavuconazole Prophylaxis
por: DeVoe, Catherine, et al.
Publicado: (2018)

2100. Epidemiology and Risk Factors for Invasive Fungal Infections Among Patients with Hematological Malignancies In Colombia
por: Ortiz-Martínez, Yeimer, et al.
Publicado: (2022)

2596. Title: The Dynamics Of Invasive Pneumococcal Disease (IPD) due to Streptococcus pneumoniae and Impact Of Pneumococcal Conjugate Vaccines (PCVs) In Canada From 2000-2019
por: Ramos, Bernice N, et al.
Publicado: (2023)

755. Posaconazole versus voriconazole as antifungal prophylaxis for invasive fungal diseases in patients with hematological malignancies
por: Almutairy, Reem F, et al.
Publicado: (2020)

Invasive Fungal Infections and Targeted Therapies in Hematological Malignancies
por: Little, Jessica S., et al.
Publicado: (2021)

1557. Acyclovir-Resistant (ACV-R) Herpes Simplex Virus (HSV) Disease in Patients with Hematologic Malignancies (HM) and Hematopoietic-Cell Transplant (HCT) Recipients
por: Pandit, Alisha, et al.
Publicado: (2018)

1730. Invasive Fusarium Species in Mayo Clinic Patients with Hematologic Malignancies
por: Harris, Courtney, et al.
Publicado: (2019)

Invasive Fungal Infections at Presentation of Untreated Hematologic Malignancies: Rare and Elusive
por: Spallone, Amy, et al.
Publicado: (2020)

1740. Title: Outcomes of a Clinical Algorithm for the Early Diagnosis and Treatment of Invasive Fungal Sinusitis among Children with Hematologic Malignancy or Prior Hematopoietic Stem Cell Transplantation
por: Warraich, Gohar, et al.
Publicado: (2019)

Risk Prediction and Prognosis of Invasive Fungal Disease in Hematological Malignancies Patients Complicated with Bloodstream Infections
por: Xiao, Han, et al.
Publicado: (2020)

1182. The Real-World Use of Isavuconazole as Primary or salvage Therapy of Invasive Fungal infections in High-Risk Patients with Hematologic Malignancy or Stem Cell Transplant
por: dagher, Hiba, et al.
Publicado: (2020)

Master regulatory GATA transcription factors: mechanistic principles and emerging links to hematologic malignancies
por: Bresnick, Emery H., et al.
Publicado: (2012)

Invasive Fungal Carotiditis: A Rare Manifestation of Cranial Invasive Fungal Disease: Case Series and Systematic Review of the Literature
por: Little, Jessica S, et al.
Publicado: (2019)

Comparing Diagnostic-Driven Approaches to Empiric Therapy in the Treatment of Invasive Aspergillosis in Patients with Hematologic Malignancy
por: Dib, Rita Wilson, et al.
Publicado: (2017)

355. Invasive Pulmonary Aspergillosis (IPA) Complicating Respiratory Viral Infections in Patients With Hematological Malignancies
por: Magira, Eleni, et al.
Publicado: (2018)

Role of Iron and Iron Overload in the Pathogenesis of Invasive Fungal Infections in Patients with Hematological Malignancies
por: Valković, Toni, et al.
Publicado: (2022)

2709. Breakthrough fungal infection after isavuconazole primary prophylaxis in patients with hematologic malignancy and hematopoietic stem cell transplant: Systematic Review
por: Ishida, Keiko, et al.
Publicado: (2023)

268. Fungal NGS: Identification of Etiological Agents of Invasive Fungal Infection by High-throughput Sequencing
por: Nelsen, Donald J, et al.
Publicado: (2019)

1701. Trends in Invasive Candidiasis in Children with Hematologic Malignancies: Increased Risk of Dissemination with Non-albicans Candida
por: Said, Amira, et al.
Publicado: (2023)

Defining Invasive Fungal Infection Risk in Hematological Malignancies: A New Tool for Clinical Practice
por: Rambaldi, Benedetta, et al.
Publicado: (2017)

Invasive Fungal Infections in Patients with Hematological Malignancies: Emergence of Resistant Pathogens and New Antifungal Therapies
por: Gamaletsou, Maria N., et al.
Publicado: (2018)

Antifungal Strategy in Patients with Invasive Fungal Disease Associated with Hematological Malignancies Based on Risk Stratification
por: Chen, Lijin, et al.
Publicado: (2022)

1095. Investigation of Risk Factors Associated with Serious Bacterial, Viral and Invasive Fungal Infections in Hematologic Patients on Ibrutinib
por: Holowka, Thomas, et al.
Publicado: (2020)

Surgery for Pulmonary Fungal Infections Complicating Hematological Malignancies
por: Yamamichi, Takashi, et al.
Publicado: (2018)

272. Invasive Pulmonary Aspergillosis: Comparative Analysis in cancer patients with Underlying Hematologic Malignancy vs. Solid Tumor
por: Wilson Dib, Rita, et al.
Publicado: (2019)

PB2596: OPTIMIZING PLATELET TRANSFUSION FOR CLINICAL PRACTICE. DO PLATELETS AGE MATTER FOR THERAPEUTIC PLATELETS TRANSFUSION?
por: Attallah, Samy, et al.
Publicado: (2023)

Antifungal Resistance and Predictors of Response in Patients with Hematologic Malignancy
por: Wey, Shiuan (Shannon), et al.
Publicado: (2017)

2120. Respiratory Viral Infections in Patients with Hematologic Malignancies
por: Cardenas, Jorge Luis, et al.
Publicado: (2022)

Invasive fungal sinusitis in patients with hematological malignancy: 15 years experience in a single university hospital in Taiwan
por: Chen, Chien-Yuan, et al.
Publicado: (2011)

360. Breakthrough Invasive Pulmonary Aspergillosis During Isavuconazole Prophylaxis in Patients with Hematologic Malignancies: A Single-Center Experience
por: Fontana, Lauren, et al.
Publicado: (2018)

359. Baseline Serum Aspergillus Galactomannan Index Among Aspergillus Species in Hematologic Malignancies Patients With Invasive Pulmonary Aspergillosis
por: Magira, Eleni, et al.
Publicado: (2018)

755. Predictors of Mortality in Invasive Mold Infections Among Patients with Hematologic Malignancies and Hematopoietic Stem Cell Transplant Recipients
por: Gupta, Aanchal, et al.
Publicado: (2022)

828. Do lung co-infections influence outcome in patients with hematological malignancies and culture-documented invasive pulmonary aspergillosis?
por: Matsuo, Takahiro, et al.
Publicado: (2023)

848. Discordant Chest Radiography and Computed Tomography Findings in Patients with Hematologic Malignancy and Invasive Mucormycosis: What Are the Prognostic Implications?
por: Wurster, Sebastian, et al.
Publicado: (2023)

Secondary Antifungal Prophylaxis in Hematological Malignancy Patients with Previous Invasive Fungal Disease: A Retrospective Analysis
por: Liu, Mingjuan, et al.
Publicado: (2014)

INVASIVE FUNGAL INFECTIONS IN CHILDREN TREATED FOR HEMATOLOGIC MALIGNANCIES – A FIVE-YEAR SINGLE CENTER EXPERIENCE
por: Buljan, Domagoj, et al.
Publicado: (2022)

Opportunistic Infections (OIs) in Patients with Hematologic Malignancies (HM) Treated with Bruton’s Tyrosine Kinase (BTK) and Phosphoinositide 3 Kinase (PI3K) Inhibitors: An 8-Year Retrospective Cohort Study
por: Issa, Nicolas, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_soc8s0odqdj19hk9mf5fbhkh4m